Difference between revisions of "Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5 (Q9625)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1016/j.pharmthera.2017.02.037, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: PubMed ID (P140): 28216025, #quickstatements; #temporary_batch_1590001671040) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 28216025 / rank | |||
| + | Normal rank | ||
Revision as of 19:15, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Dey N, et al. Pharmacol. Ther. (2017) cited as Ref 362 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Dey N
0 references
De P
0 references
Leyland-Jones B
0 references
